Literature DB >> 217866

High and selective resistance to mecillinam in adenylate cyclase-deficient or cyclic adenosine 3',5'-monophosphate receptor protein-deficient mutants of Escherichia coli.

R Aono, M Yamasaki, G Tamura.   

Abstract

Adenylate cyclase-deficient (cya) mutants of Escherichia coli K-12 were selectively and highly resistant to mecillinam (FL1060) among several beta-lactam antibiotics in the absence of cyclic adenosine 3',5'-monophosphate (cAMP). They became sensitive to the drug in the presence of cAMP. Also, cAMP receptor protein-negative (crp) mutants, with the exception of strain 5333, were highly resistant to mecillinam in the presence and in the absence of cAMP. Mecillinam exerted two distinct and sequential effects in both cya+ strains and cya strains supplemented with cAMP: (i) rounding of cells and (ii) cessation of cell division. The first effect was accompanied by a decrease in growth rate, whereas the second effect was accompanied by enlargement and lysis of the rounded cells. The second effect of mecillinam was dependent on inoculum size and cAMP. When the cell density was above about 10(6) cells per ml, the rounded cells stopped dividing but did not lyse. In the absence of cAMP, cya strains neither stopped dividing nor lysed; they were resistant to the second, lethal effect of mecillinam.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 217866      PMCID: PMC218365          DOI: 10.1128/jb.137.2.839-845.1979

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  16 in total

1.  Changes in composition of envelope proteins in adenylate cyclase- or cyclic AMP receptor protein-deficient mutants of Escherichia coli.

Authors:  R Aono; M Yamasaki; G Tamura
Journal:  J Bacteriol       Date:  1978-11       Impact factor: 3.490

2.  Properties of adenyl cyclase and cyclic adenosine 3',5'-monophosphate receptor protein-deficient mutants of Escherichia coli.

Authors:  S Kumar
Journal:  J Bacteriol       Date:  1976-02       Impact factor: 3.490

3.  Deletion of the Escherichia coli crp gene.

Authors:  D Sabourin; J Beckwith
Journal:  J Bacteriol       Date:  1975-04       Impact factor: 3.490

4.  Suppression of lytic effect of beta lactams on Escherichia coli and other bacteria.

Authors:  E W Goodell; R Lopez; A Tomasz
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

5.  FL-1060: a new penicillin with a unique mode of action.

Authors:  J T Park; L Burman
Journal:  Biochem Biophys Res Commun       Date:  1973-04-16       Impact factor: 3.575

6.  Genetic characterization of mutations which affect catabolite-sensitive operons in Escherichia coli, including deletions of the gene for adenyl cyclase.

Authors:  E Brickman; L Soll; J Beckwith
Journal:  J Bacteriol       Date:  1973-11       Impact factor: 3.490

7.  Cyclic AMP receptor protein of E. coli: its role in the synthesis of inducible enzymes.

Authors:  M Emmer; B deCrombrugghe; I Pastan; R Perlman
Journal:  Proc Natl Acad Sci U S A       Date:  1970-06       Impact factor: 11.205

8.  6 -amidinopenicillanic acids--a new group of antibiotics.

Authors:  F Lund; L Tybring
Journal:  Nat New Biol       Date:  1972-04-05

9.  Comparison of the binding properties of two 6 beta-amidinopenicillanic acid derivatives that differ in their physiological effects on Escherichia coli.

Authors:  B G Spratt
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

10.  Mechanism of action and development of resistance to a new amidino penicillin.

Authors:  S Matsuhashi; T Kamiryo; P M Blumberg; P Linnett; E Willoughby; J L Strominger
Journal:  J Bacteriol       Date:  1974-02       Impact factor: 3.490

View more
  18 in total

1.  Penicillin-binding protein 2 is essential in wild-type Escherichia coli but not in lov or cya mutants.

Authors:  T Ogura; P Bouloc; H Niki; R D'Ari; S Hiraga; A Jaffé
Journal:  J Bacteriol       Date:  1989-06       Impact factor: 3.490

2.  Cyclic AMP and cell division in Escherichia coli.

Authors:  R D'Ari; A Jaffé; P Bouloc; A Robin
Journal:  J Bacteriol       Date:  1988-01       Impact factor: 3.490

3.  Buoyant density studies of several mecillinam-resistant and division mutants of Escherichia coli.

Authors:  J E Bylund; M A Haines; K Walsh; P Bouloc; R D'Ari; M L Higgins
Journal:  J Bacteriol       Date:  1991-09       Impact factor: 3.490

4.  SOS-independent coupling between DNA replication and cell division in Escherichia coli.

Authors:  A Jaffé; R D'Ari; V Norris
Journal:  J Bacteriol       Date:  1986-01       Impact factor: 3.490

5.  Amdinocillin (Mecillinam) resistance mutations in clinical isolates and laboratory-selected mutants of Escherichia coli.

Authors:  Elisabeth Thulin; Martin Sundqvist; Dan I Andersson
Journal:  Antimicrob Agents Chemother       Date:  2015-01-12       Impact factor: 5.191

6.  Round-cell mutants of Salmonella typhimurium produced by transposition mutagenesis: lethality of rodA and mre mutations.

Authors:  C S Costa; D N Antón
Journal:  Mol Gen Genet       Date:  1993-01

Review 7.  Cyclic nucleotides in procaryotes.

Authors:  J L Botsford
Journal:  Microbiol Rev       Date:  1981-12

8.  Penicillin-binding protein 2 inactivation in Escherichia coli results in cell division inhibition, which is relieved by FtsZ overexpression.

Authors:  D Vinella; D Joseleau-Petit; D Thévenet; P Bouloc; R D'Ari
Journal:  J Bacteriol       Date:  1993-10       Impact factor: 3.490

9.  Treatment of experimental Salmonella typhimurium infection with mecillinam and ampicillin.

Authors:  T Butler; C W Shuster; P Dixon
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

10.  Postantibiotic effect of imipenem on Pseudomonas aeruginosa.

Authors:  C I Bustamante; G L Drusano; B A Tatem; H C Standiford
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.